The results confirmed our findings, demonstrating a significant association between higher EMX2 expression and relapse-free survival (RFS) in esophageal squamous cell carcinoma (ESCC) (n = 81, HR = 2.71, log-rank p = 0.042, Figure S4). Here, EMX2 is linked to esophageal squamous cell carcinoma.